During the last session, Zai Lab Limited ADR (NASDAQ:ZLAB)’s traded shares were 1.03 million, with the beta value of the company hitting 1.00. At the end of the trading day, the stock’s price was $28.36, reflecting an intraday loss of -3.47% or -$1.02. The 52-week high for the ZLAB share is $39.77, that puts it down -40.23 from that peak though still a striking 43.55% gain since the share price plummeted to a 52-week low of $16.01. The company’s market capitalization is $3.12B, and the average trade volume was 1.26 million shares over the past three months.
Zai Lab Limited ADR (ZLAB) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.29. ZLAB has a Sell rating from 0 analyst(s) out of 2 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 2 recommend a Buy rating for it.
Zai Lab Limited ADR (NASDAQ:ZLAB) trade information
Zai Lab Limited ADR (ZLAB) registered a -3.47% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -3.47% in intraday trading to $28.36, hitting a weekly high. The stock’s 5-day price performance is -10.51%, and it has moved by -1.54% in 30 days. Based on these gigs, the overall price performance for the year is 74.52%.
The consensus price target of analysts on Wall Street is $55, which implies an increase of 48.44% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $55 and $55 respectively. As a result, ZLAB is trading at a discount of -93.94% off the target high and -93.94% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -3.18%. While earnings are projected to return 42.96% in 2025.
ZLAB Dividends
Zai Lab Limited ADR is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 6.53 million shares, is of JANUS HENDERSON GROUP PLC’s that is approximately 0.6689% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $113.13 million.
Also, the Mutual Funds coming in first place with the largest holdings of Zai Lab Limited ADR (ZLAB) shares are New World Fund Inc and VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund . Data provided on Mar 31, 2025 indicates that New World Fund Inc owns about 3.27 shares. This amounts to just over 2.97 percent of the company’s overall shares, with a $92.85 million market value. The same data shows that the other fund manager holds slightly less at 2.9, or about 2.62% of the stock, which is worth about $82.13 million.
